CTRI/2020/04/024765尚未招募2 期
A RANDOMIZED, PARALLEL GROUP, OPEN LABEL, STANDARD CONTROLLED CLINICAL STUDY TO COMPARE THE EFFICACY AND SAFETY OF UNANI FORMULATIONS- QURS-E- ASFAR(O) AND ROGHAN-I-NARJIL(L) WITH ITRACONAZOLE(O) AND TERBINAFINE(L) IN THE MANAGEMENT OF QŪBÄ?(DERMATOPHYTOSIS) - PGDT
ational Research Institute of Unani Medicine for Skin Disorders0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •The participants will be included in the study on the basis of the following criteria:
- •1.Circumscribed lesions having any of the following signs and symptoms on body and limbs:
- •Presence of pruritus and burning,
- •Presence of scales,
- •Presence of central clearing,
- •Erythematous papules.
- •2.Participants with positive mycology (KOH positive).
- •3.Participants of either sex in age group of 18-60 years
排除标准
- •The following participants will be excluded:
- •1.Co-morbid conditions of the participants
- •2.Pregnant or Lactating Women
- •3.Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction
- •4.Known cases of Immuno-compromised states (HIV/ AIDS, etc.)/ Malignancies
- •5.Participants not willing to attend treatment schedule regularly
- •6.History of hypersensitivity to Itraconazole and Terbinafine.
- •7.Participants using the following medications:
- •Systemic antifungal within 15 days of baseline visit.
- •Systemic corticosteroids within 15 days of baseline visit.
研究者
相似试验
已完成
3 期
6-WEEK TRIAL OF THE EFFICACY AND SAFETY OF ASENAPINE COMPARED TO RISPERIDONE IN ADULT PATIENT WITH ACUTE EXACERBATION OF SCHIZOPHRENIACTRI/2010/091/000423Intas Pharmaceuticals Limited280
Unknown
3 期
13-WEEK STUDY FOR EVALUATION OF EFFICACY AND SAFETY OF IN-AQUL-002 TABLET COMPARED TO OXCARBAZEPINE SUSTAINED-RELEASE TABLET AS ADJUNCTIVE TREATEMENT IN ADULT PATIENTS WITH REFRACTORY PARTIAL-ONSET SEIZURESCTRI/2010/091/006085Intas Pharmaceuticals Limited270
Unknown
3 期
PHASE III CLINICAL TRIAL FOR EVALUATION OF EFFICACY AND SAFETY OF IN-PHRM-001 IN COMPARISON WITH ALLOPURINOL IN ADULT PATIENTS WITH GOUT.CTRI/2009/091/001087Intas Pharmaceuticals Limited270
已完成
3 期
Phase III clinical trial for Evaluation of Efficacy and Safety of IN-PHARM-002 in Comparison with Ibuprofen in adult patients with acute painful soft tissue injury.CTRI/2009/091/001067Intas Pharmaceuticals Limited204
已完成
3 期
CLINICAL TRIAL FOR EVALUATION OF EFFICACY AND SAFETY OF PRASUGREL IN COMPARISON WITH CLOPIDOGREL IN ACUTE CORONARY SYNDROME (ACS) PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI).CTRI/2009/091/001085Intas Pharmaceuticals Limited240